BBVA
ADMS

Banco Bilbao Vizcaya Argentaria’s Adamas Pharmaceuticals ADMS Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100,000
Closed -$256K – 798
2020
Q2 		$256K Buy
+100,000
New +$294K 0.01% 659

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ADMS Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Adamas Pharmaceuticals (ADMS) in Q3 2020, closing a stake of 100,000 shares — an estimated $256K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ADMS in Q2 2020 and held it in 1 quarter. The position peaked at $256K in Q2 2020. 63 funds tracked by Wall St. Rank hold ADMS as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Adamas Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 100,000 Adamas Pharmaceuticals shares in Q3 2020, an estimated $256K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Adamas Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Adamas Pharmaceuticals position peaked at $256K in Q2 2020.
  • 63 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.